Abstract
In 118 previous hepatitis B surface antigen (HBsAg) carriers, low-level hepatitis B (HBV) viremia persisted at a rate of 15%-20% for >10 years after HBsAg seroclearance. The frequency of HBV viremia was significantly (P =. 002) lower in patients with anti-HBsAg seroconversion (6 of 69 [8.7%]) than in those without seroconversion (15 of 49 [30.6%]).
Original language | English |
---|---|
Pages (from-to) | 88-90 |
Number of pages | 3 |
Journal | Clinical Infectious Diseases |
Volume | 54 |
Issue number | 1 |
DOIs | |
State | Published - 01 01 2012 |